KATHY MARTIN: Open Payments
NPI 1215978390 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,057 in 11 payments from 8 companies in 2025. Trend: 2023 $1,266 · 2024 $1,105 · 2025 $1,057
Food & beverage: $1,057
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $373 |
| Amgen Inc. | 1 | $148 |
| Novo Nordisk Inc | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 1 | $118 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $98 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $96 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $86 |
| Abbott Laboratories | 1 | $16 |
Products named: Auvelity, AUSTEDO XR, Tryvio, PROCLAIM.
Industry payments across AL — which companies pay providers there.
